Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Voltage-gated potassium channels control extended access cocaine seeking: a role for nucleus accumbens astrocytes
    Published on 2023-09-02
    2 years ago
  • Refining the study of decision-making in animals: differential effects of d-amphetamine and haloperidol in a novel touchscreen-automated Rearing-Effort Discounting (RED) task and the Fixed-Ratio Effort Discounting (FRED) task
    Published on 2023-08-29
    2 years ago
  • Delayed estrogen actions diminish food consumption without changing food approach, motor activity, or hypothalamic activation elicited by corticostriatal µ-opioid signaling
    Published on 2023-08-28
    2 years ago
  • Correction: High-intensity sweet taste as a predictor of subjective alcohol responses to the ascending limb of an intravenous alcohol prime: an fMRI study
    Published on 2023-08-28
    2 years ago
  • Correction: Accelerated TMS – moving quickly into the future of depression treatment
    Published on 2023-08-28
    2 years ago
  • Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits
    Published on 2023-08-22
    2 years ago
  • Novel mechanism-based treatments for pediatric anxiety and depressive disorders
    Published on 2023-08-22
    2 years ago
« Previous 1 … 64 65 66 67 68 … 143 Next »
Journal of Psychopharmacology
  • Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group
    Published on 2021-08-04
    4 years ago
  • Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?
    Published on 2021-08-04
    4 years ago
  • Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials
    Published on 2021-07-31
    4 years ago
  • The Journal of Psychopharmacology: La Plus ça change. . .
    Published on 2021-07-28
    4 years ago
  • β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological–pharmacodynamic study
    Published on 2021-07-28
    4 years ago
  • Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology
    Published on 2021-07-28
    4 years ago
  • Individualizing tapering antipsychotic schemes considering D2 blockade dynamics
    Published on 2021-07-27
    4 years ago
« Previous 1 … 64 65 66 67 68 … 124 Next »
European Neuropsychopharmacology
  • The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations
    Published on 2022-05-10
    3 years ago
  • Depression, antidepressants, and insulin resistance: which link?
    Published on 2022-05-09
    3 years ago
  • Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study
    Published on 2022-05-09
    3 years ago
  • Association between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder
    Published on 2022-05-09
    3 years ago
  • Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications
    Published on 2022-04-15
    3 years ago
  • Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?
    Published on 2022-04-07
    3 years ago
  • Mechanisms of action of anti-bipolar drugs
    Published on 2022-04-07
    3 years ago
« Previous 1 … 64 65 66 67 68 … 145 Next »

   Pharma Pub